APO Research
Talk to an analyst

APO RESEARCH · REPORT

Phage Display Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Phage Display Service Market Outlook and Growth Opportunities 2026

5 March 2026210 pages

Choose your research edition.

Industry ResearchPhage Display Service Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Phage Display Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Phage Display Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Phage Display Service Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Phage Display Service Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Phage Display Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Phage Display Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Phage Display Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Phage Display Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Phage Display Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Phage Display Service market include Creative Biogene, Creative Biolabs, ProteoGenix, CUSABIO, Diaclone, Biomolecular Discovery Services, Charles River, GenScript and Synbio Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Phage Display Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Phage Display Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Phage Display Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Phage Display Service market.

Phage Display Service Segment by Company

Creative Biogene

Creative Biolabs

ProteoGenix

CUSABIO

Diaclone

Biomolecular Discovery Services

Charles River

GenScript

Synbio Technologies

Creative Peptides

ProImmune

Absolute Antibody

Iontas

LakePharma

KMD Bioscience

NeoClone

Pepscan

Abzena

ChemPartner

Creative Proteomics

Yntoab

Diane biological

Biosynth

Zoonbio Biotechnology

Abiocenter

Phage Display Service Segment by Type

cDNA Library

Antibody Library

Protein Library

Random Peptide Library

Phage Display Service Segment by Application

Immunotherapy

Drug Discovery

Functional Genomics

Others

Phage Display Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Phage Display Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Phage Display Service key companies, revenue, market share, and recent developments.

3. To split the Phage Display Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Phage Display Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Phage Display Service significant trends, drivers, influence factors in global and regions.

6. To analyze Phage Display Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Display Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Phage Display Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Display Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Phage Display Service industry.

Chapter 3: Detailed analysis of Phage Display Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Phage Display Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Phage Display Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Phage Display Service Industry Trends Table 2. Phage Display Service Industry Drivers Table 3. Phage Display Service Industry Opportunities and Challenges Table 4. Phage Display Service Industry Restraints Table 5. Global Phage Display Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Phage Display Service Revenue Share by Company (2021-2026) Table 7. Global Phage Display Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Phage Display Service Key Company Manufacturing Base & Headquarters Table 9. Global Phage Display Service Company, Product Type & Application Table 10. Global Phage Display Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Phage Display Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of cDNA Library Table 15. Significant Companies of Antibody Library Table 16. Significant Companies of Protein Library Table 17. Significant Companies of Random Peptide Library Table 18. Global Phage Display Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Phage Display Service Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Phage Display Service Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Phage Display Service Sales Value Share by Type (2021-2026) Table 22. Global Phage Display Service Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Immunotherapy Table 24. Significant Companies of Drug Discovery Table 25. Significant Companies of Functional Genomics Table 26. Significant Companies of Others Table 27. Global Phage Display Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Phage Display Service Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Phage Display Service Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Phage Display Service Sales Value Share by Application (2021-2026) Table 31. Global Phage Display Service Sales Value Share by Application (2027-2032) Table 32. Global Phage Display Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Phage Display Service Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Phage Display Service Sales Value Share by Region (2021-2026) Table 35. Global Phage Display Service Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Phage Display Service Sales Value Share by Region (2027-2032) Table 37. Global Phage Display Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Phage Display Service Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Phage Display Service Sales Value Market Share by Country (2021-2026) Table 40. Global Phage Display Service Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Phage Display Service Sales Value Market Share by Country (2027-2032) Table 42. Creative Biogene Company Information Table 43. Creative Biogene Business Overview Table 44. Creative Biogene Phage Display Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Creative Biogene Phage Display Service Product Portfolio Table 46. Creative Biogene Recent Development Table 47. Creative Biolabs Company Information Table 48. Creative Biolabs Business Overview Table 49. Creative Biolabs Phage Display Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Creative Biolabs Phage Display Service Product Portfolio Table 51. Creative Biolabs Recent Development Table 52. ProteoGenix Company Information Table 53. ProteoGenix Business Overview Table 54. ProteoGenix Phage Display Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. ProteoGenix Phage Display Service Product Portfolio Table 56. ProteoGenix Recent Development Table 57. CUSABIO Company Information Table 58. CUSABIO Business Overview Table 59. CUSABIO Phage Display Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. CUSABIO Phage Display Service Product Portfolio Table 61. CUSABIO Recent Development Table 62. Diaclone Company Information Table 63. Diaclone Business Overview Table 64. Diaclone Phage Display Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Diaclone Phage Display Service Product Portfolio Table 66. Diaclone Recent Development Table 67. Biomolecular Discovery Services Company Information Table 68. Biomolecular Discovery Services Business Overview Table 69. Biomolecular Discovery Services Phage Display Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Biomolecular Discovery Services Phage Display Service Product Portfolio Table 71. Biomolecular Discovery Services Recent Development Table 72. Charles River Company Information Table 73. Charles River Business Overview Table 74. Charles River Phage Display Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Charles River Phage Display Service Product Portfolio Table 76. Charles River Recent Development Table 77. GenScript Company Information Table 78. GenScript Business Overview Table 79. GenScript Phage Display Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GenScript Phage Display Service Product Portfolio Table 81. GenScript Recent Development Table 82. Synbio Technologies Company Information Table 83. Synbio Technologies Business Overview Table 84. Synbio Technologies Phage Display Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Synbio Technologies Phage Display Service Product Portfolio Table 86. Synbio Technologies Recent Development Table 87. Creative Peptides Company Information Table 88. Creative Peptides Business Overview Table 89. Creative Peptides Phage Display Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Creative Peptides Phage Display Service Product Portfolio Table 91. Creative Peptides Recent Development Table 92. ProImmune Company Information Table 93. ProImmune Business Overview Table 94. ProImmune Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. ProImmune Phage Display Service Product Portfolio Table 96. ProImmune Recent Development Table 97. Absolute Antibody Company Information Table 98. Absolute Antibody Business Overview Table 99. Absolute Antibody Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Absolute Antibody Phage Display Service Product Portfolio Table 101. Absolute Antibody Recent Development Table 102. Iontas Company Information Table 103. Iontas Business Overview Table 104. Iontas Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Iontas Phage Display Service Product Portfolio Table 106. Iontas Recent Development Table 107. LakePharma Company Information Table 108. LakePharma Business Overview Table 109. LakePharma Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. LakePharma Phage Display Service Product Portfolio Table 111. LakePharma Recent Development Table 112. KMD Bioscience Company Information Table 113. KMD Bioscience Business Overview Table 114. KMD Bioscience Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. KMD Bioscience Phage Display Service Product Portfolio Table 116. KMD Bioscience Recent Development Table 117. NeoClone Company Information Table 118. NeoClone Business Overview Table 119. NeoClone Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. NeoClone Phage Display Service Product Portfolio Table 121. NeoClone Recent Development Table 122. Pepscan Company Information Table 123. Pepscan Business Overview Table 124. Pepscan Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Pepscan Phage Display Service Product Portfolio Table 126. Pepscan Recent Development Table 127. Abzena Company Information Table 128. Abzena Business Overview Table 129. Abzena Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Abzena Phage Display Service Product Portfolio Table 131. Abzena Recent Development Table 132. ChemPartner Company Information Table 133. ChemPartner Business Overview Table 134. ChemPartner Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. ChemPartner Phage Display Service Product Portfolio Table 136. ChemPartner Recent Development Table 137. Creative Proteomics Company Information Table 138. Creative Proteomics Business Overview Table 139. Creative Proteomics Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Creative Proteomics Phage Display Service Product Portfolio Table 141. Creative Proteomics Recent Development Table 142. Yntoab Company Information Table 143. Yntoab Business Overview Table 144. Yntoab Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 145. Yntoab Phage Display Service Product Portfolio Table 146. Yntoab Recent Development Table 147. Diane biological Company Information Table 148. Diane biological Business Overview Table 149. Diane biological Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 150. Diane biological Phage Display Service Product Portfolio Table 151. Diane biological Recent Development Table 152. Biosynth Company Information Table 153. Biosynth Business Overview Table 154. Biosynth Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 155. Biosynth Phage Display Service Product Portfolio Table 156. Biosynth Recent Development Table 157. Zoonbio Biotechnology Company Information Table 158. Zoonbio Biotechnology Business Overview Table 159. Zoonbio Biotechnology Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 160. Zoonbio Biotechnology Phage Display Service Product Portfolio Table 161. Zoonbio Biotechnology Recent Development Table 162. Abiocenter Company Information Table 163. Abiocenter Business Overview Table 164. Abiocenter Phage Display Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 165. Abiocenter Phage Display Service Product Portfolio Table 166. Abiocenter Recent Development Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Phage Display Service Product Image Figure 2. Global Phage Display Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Phage Display Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Phage Display Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. cDNA Library Image Figure 8. Antibody Library Image Figure 9. Protein Library Image Figure 10. Random Peptide Library Image Figure 11. Global Phage Display Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Phage Display Service Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Phage Display Service Sales Value Share by Type (2021-2032) Figure 14. Immunotherapy Image Figure 15. Drug Discovery Image Figure 16. Functional Genomics Image Figure 17. Others Image Figure 18. Global Phage Display Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Phage Display Service Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Phage Display Service Sales Value Share by Application (2021-2032) Figure 21. Global Phage Display Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Phage Display Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Phage Display Service Sales Value (2021-2032) & (US$ Million) Figure 24. North America Phage Display Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Phage Display Service Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Phage Display Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Phage Display Service Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Phage Display Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Phage Display Service Sales Value (2021-2032) & (US$ Million) Figure 30. South America Phage Display Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Phage Display Service Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Phage Display Service Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Phage Display Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Phage Display Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Phage Display Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • cDNA Library
  • Antibody Library
  • Protein Library
  • Random Peptide Library
Applications
  • Immunotherapy
  • Drug Discovery
  • Functional Genomics
  • Others
Companies covered
  • Creative Biogene
  • Creative Biolabs
  • ProteoGenix
  • CUSABIO
  • Diaclone
  • Biomolecular Discovery Services
  • Charles River
  • GenScript
  • Synbio Technologies
  • Creative Peptides
  • ProImmune
  • Absolute Antibody
  • Iontas
  • LakePharma
  • KMD Bioscience
  • NeoClone
  • Pepscan
  • Abzena
  • ChemPartner
  • Creative Proteomics
  • Yntoab
  • Diane biological
  • Biosynth
  • Zoonbio Biotechnology
  • Abiocenter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Phage Display Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Phage Display Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Phage Display Service Market Dynamics
  1. 2.1 Phage Display Service Industry Trends
  2. 2.2 Phage Display Service Industry Drivers
  3. 2.3 Phage Display Service Industry Opportunities and Challenges
  4. 2.4 Phage Display Service Industry Restraints
3 Phage Display Service Market by Company
  1. 3.1 Global Phage Display Service Company Revenue Ranking in 2025
  2. 3.2 Global Phage Display Service Revenue by Company (2021-2026)
  3. 3.3 Global Phage Display Service Company Ranking (2024-2026)
  4. 3.4 Global Phage Display Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Phage Display Service Company Product Type and Application
  6. 3.6 Global Phage Display Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Phage Display Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Phage Display Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Phage Display Service Market by Type
  1. 4.1 Phage Display Service Type Introduction
  2. 4.1.1 cDNA Library
  3. 4.1.2 Antibody Library
  4. 4.1.3 Protein Library
  5. 4.1.4 Random Peptide Library
  6. 4.2 Global Phage Display Service Sales Value by Type
  7. 4.2.1 Global Phage Display Service Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Phage Display Service Sales Value by Type (2021-2032)
  9. 4.2.3 Global Phage Display Service Sales Value Share by Type (2021-2032)
5 Phage Display Service Market by Application
  1. 5.1 Phage Display Service Application Introduction
  2. 5.1.1 Immunotherapy
  3. 5.1.2 Drug Discovery
  4. 5.1.3 Functional Genomics
  5. 5.1.4 Others
  6. 5.2 Global Phage Display Service Sales Value by Application
  7. 5.2.1 Global Phage Display Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Phage Display Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Phage Display Service Sales Value Share by Application (2021-2032)
6 Phage Display Service Regional Value Analysis
  1. 6.1 Global Phage Display Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Phage Display Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Phage Display Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Phage Display Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Phage Display Service Sales Value (2021-2032)
  7. 6.3.2 North America Phage Display Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Phage Display Service Sales Value (2021-2032)
  10. 6.4.2 Europe Phage Display Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Phage Display Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Phage Display Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Phage Display Service Sales Value (2021-2032)
  16. 6.6.2 South America Phage Display Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Phage Display Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Phage Display Service Sales Value Share by Country, 2025 VS 2032
7 Phage Display Service Country-level Value Analysis
  1. 7.1 Global Phage Display Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Phage Display Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Phage Display Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Phage Display Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Phage Display Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Phage Display Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Phage Display Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Phage Display Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Phage Display Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Phage Display Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Phage Display Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Phage Display Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Phage Display Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Phage Display Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Phage Display Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Phage Display Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Phage Display Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Phage Display Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Phage Display Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Phage Display Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Phage Display Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Phage Display Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Phage Display Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Phage Display Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Phage Display Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Phage Display Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Phage Display Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Phage Display Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Phage Display Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Phage Display Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Phage Display Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Phage Display Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Phage Display Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Phage Display Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Phage Display Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Phage Display Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Phage Display Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Phage Display Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Phage Display Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Phage Display Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Phage Display Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Phage Display Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Phage Display Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Phage Display Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Phage Display Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Phage Display Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Phage Display Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Phage Display Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Phage Display Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Phage Display Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Phage Display Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Phage Display Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Phage Display Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Phage Display Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Phage Display Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Phage Display Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Phage Display Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Phage Display Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Phage Display Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Phage Display Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Phage Display Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Phage Display Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Phage Display Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Phage Display Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Phage Display Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Phage Display Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Phage Display Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Phage Display Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Phage Display Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Phage Display Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Phage Display Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Phage Display Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Phage Display Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Phage Display Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Phage Display Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Phage Display Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Phage Display Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Phage Display Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Phage Display Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Phage Display Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Phage Display Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Phage Display Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Phage Display Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Phage Display Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Phage Display Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Phage Display Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Phage Display Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Phage Display Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Creative Biogene
  2. 8.1.1 Creative Biogene Company Information
  3. 8.1.2 Creative Biogene Business Overview
  4. 8.1.3 Creative Biogene Phage Display Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Creative Biogene Phage Display Service Product Portfolio
  6. 8.1.5 Creative Biogene Recent Developments
  7. 8.2 Creative Biolabs
  8. 8.2.1 Creative Biolabs Company Information
  9. 8.2.2 Creative Biolabs Business Overview
  10. 8.2.3 Creative Biolabs Phage Display Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Creative Biolabs Phage Display Service Product Portfolio
  12. 8.2.5 Creative Biolabs Recent Developments
  13. 8.3 ProteoGenix
  14. 8.3.1 ProteoGenix Company Information
  15. 8.3.2 ProteoGenix Business Overview
  16. 8.3.3 ProteoGenix Phage Display Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ProteoGenix Phage Display Service Product Portfolio
  18. 8.3.5 ProteoGenix Recent Developments
  19. 8.4 CUSABIO
  20. 8.4.1 CUSABIO Company Information
  21. 8.4.2 CUSABIO Business Overview
  22. 8.4.3 CUSABIO Phage Display Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 CUSABIO Phage Display Service Product Portfolio
  24. 8.4.5 CUSABIO Recent Developments
  25. 8.5 Diaclone
  26. 8.5.1 Diaclone Company Information
  27. 8.5.2 Diaclone Business Overview
  28. 8.5.3 Diaclone Phage Display Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Diaclone Phage Display Service Product Portfolio
  30. 8.5.5 Diaclone Recent Developments
  31. 8.6 Biomolecular Discovery Services
  32. 8.6.1 Biomolecular Discovery Services Company Information
  33. 8.6.2 Biomolecular Discovery Services Business Overview
  34. 8.6.3 Biomolecular Discovery Services Phage Display Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biomolecular Discovery Services Phage Display Service Product Portfolio
  36. 8.6.5 Biomolecular Discovery Services Recent Developments
  37. 8.7 Charles River
  38. 8.7.1 Charles River Company Information
  39. 8.7.2 Charles River Business Overview
  40. 8.7.3 Charles River Phage Display Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Charles River Phage Display Service Product Portfolio
  42. 8.7.5 Charles River Recent Developments
  43. 8.8 GenScript
  44. 8.8.1 GenScript Company Information
  45. 8.8.2 GenScript Business Overview
  46. 8.8.3 GenScript Phage Display Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GenScript Phage Display Service Product Portfolio
  48. 8.8.5 GenScript Recent Developments
  49. 8.9 Synbio Technologies
  50. 8.9.1 Synbio Technologies Company Information
  51. 8.9.2 Synbio Technologies Business Overview
  52. 8.9.3 Synbio Technologies Phage Display Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Synbio Technologies Phage Display Service Product Portfolio
  54. 8.9.5 Synbio Technologies Recent Developments
  55. 8.10 Creative Peptides
  56. 8.10.1 Creative Peptides Company Information
  57. 8.10.2 Creative Peptides Business Overview
  58. 8.10.3 Creative Peptides Phage Display Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Creative Peptides Phage Display Service Product Portfolio
  60. 8.10.5 Creative Peptides Recent Developments
  61. 8.11 ProImmune
  62. 8.11.1 ProImmune Company Information
  63. 8.11.2 ProImmune Business Overview
  64. 8.11.3 ProImmune Phage Display Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ProImmune Phage Display Service Product Portfolio
  66. 8.11.5 ProImmune Recent Developments
  67. 8.12 Absolute Antibody
  68. 8.12.1 Absolute Antibody Company Information
  69. 8.12.2 Absolute Antibody Business Overview
  70. 8.12.3 Absolute Antibody Phage Display Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Absolute Antibody Phage Display Service Product Portfolio
  72. 8.12.5 Absolute Antibody Recent Developments
  73. 8.13 Iontas
  74. 8.13.1 Iontas Company Information
  75. 8.13.2 Iontas Business Overview
  76. 8.13.3 Iontas Phage Display Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Iontas Phage Display Service Product Portfolio
  78. 8.13.5 Iontas Recent Developments
  79. 8.14 LakePharma
  80. 8.14.1 LakePharma Company Information
  81. 8.14.2 LakePharma Business Overview
  82. 8.14.3 LakePharma Phage Display Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 LakePharma Phage Display Service Product Portfolio
  84. 8.14.5 LakePharma Recent Developments
  85. 8.15 KMD Bioscience
  86. 8.15.1 KMD Bioscience Company Information
  87. 8.15.2 KMD Bioscience Business Overview
  88. 8.15.3 KMD Bioscience Phage Display Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 KMD Bioscience Phage Display Service Product Portfolio
  90. 8.15.5 KMD Bioscience Recent Developments
  91. 8.16 NeoClone
  92. 8.16.1 NeoClone Company Information
  93. 8.16.2 NeoClone Business Overview
  94. 8.16.3 NeoClone Phage Display Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 NeoClone Phage Display Service Product Portfolio
  96. 8.16.5 NeoClone Recent Developments
  97. 8.17 Pepscan
  98. 8.17.1 Pepscan Company Information
  99. 8.17.2 Pepscan Business Overview
  100. 8.17.3 Pepscan Phage Display Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Pepscan Phage Display Service Product Portfolio
  102. 8.17.5 Pepscan Recent Developments
  103. 8.18 Abzena
  104. 8.18.1 Abzena Company Information
  105. 8.18.2 Abzena Business Overview
  106. 8.18.3 Abzena Phage Display Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Abzena Phage Display Service Product Portfolio
  108. 8.18.5 Abzena Recent Developments
  109. 8.19 ChemPartner
  110. 8.19.1 ChemPartner Company Information
  111. 8.19.2 ChemPartner Business Overview
  112. 8.19.3 ChemPartner Phage Display Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 ChemPartner Phage Display Service Product Portfolio
  114. 8.19.5 ChemPartner Recent Developments
  115. 8.20 Creative Proteomics
  116. 8.20.1 Creative Proteomics Company Information
  117. 8.20.2 Creative Proteomics Business Overview
  118. 8.20.3 Creative Proteomics Phage Display Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Creative Proteomics Phage Display Service Product Portfolio
  120. 8.20.5 Creative Proteomics Recent Developments
  121. 8.21 Yntoab
  122. 8.21.1 Yntoab Company Information
  123. 8.21.2 Yntoab Business Overview
  124. 8.21.3 Yntoab Phage Display Service Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Yntoab Phage Display Service Product Portfolio
  126. 8.21.5 Yntoab Recent Developments
  127. 8.22 Diane biological
  128. 8.22.1 Diane biological Company Information
  129. 8.22.2 Diane biological Business Overview
  130. 8.22.3 Diane biological Phage Display Service Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Diane biological Phage Display Service Product Portfolio
  132. 8.22.5 Diane biological Recent Developments
  133. 8.23 Biosynth
  134. 8.23.1 Biosynth Company Information
  135. 8.23.2 Biosynth Business Overview
  136. 8.23.3 Biosynth Phage Display Service Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Biosynth Phage Display Service Product Portfolio
  138. 8.23.5 Biosynth Recent Developments
  139. 8.24 Zoonbio Biotechnology
  140. 8.24.1 Zoonbio Biotechnology Company Information
  141. 8.24.2 Zoonbio Biotechnology Business Overview
  142. 8.24.3 Zoonbio Biotechnology Phage Display Service Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Zoonbio Biotechnology Phage Display Service Product Portfolio
  144. 8.24.5 Zoonbio Biotechnology Recent Developments
  145. 8.25 Abiocenter
  146. 8.25.1 Abiocenter Company Information
  147. 8.25.2 Abiocenter Business Overview
  148. 8.25.3 Abiocenter Phage Display Service Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Abiocenter Phage Display Service Product Portfolio
  150. 8.25.5 Abiocenter Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst